156 related articles for article (PubMed ID: 14582498)
21. Particularities of clinical investigation with biotechnology products.
Alsar MJ
Methods Find Exp Clin Pharmacol; 1999; 21 Suppl B():11-3. PubMed ID: 10599038
[No Abstract] [Full Text] [Related]
22. Who's afraid of biotechnology?
Tait J
New Sci; 1992 Jun; 134(1827):49. PubMed ID: 16044585
[No Abstract] [Full Text] [Related]
23. The monster's laws: a legal history of chimera research.
Appel JM
Genewatch; 2006; 19(2):12-6. PubMed ID: 16789302
[No Abstract] [Full Text] [Related]
24. Intellectual property in higher life forms: the patent system and controversial technologies.
Merges RP
MD Law Rev; 1988; 47(4):1051-75. PubMed ID: 16514761
[No Abstract] [Full Text] [Related]
25. Light, fast, and flexible: a new approach to regulation of human gene therapy.
Cregan JA
McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
[No Abstract] [Full Text] [Related]
26. Washington Insider: Congressional impasse on human cloning.
Doerflinger RM
Natl Cathol Bioeth Q; 2004; 4(1):19-25. PubMed ID: 15192847
[No Abstract] [Full Text] [Related]
27. Does patenting genes change the meaning of life?
Thompson RE
Physician Exec; 2003; 29(3):40-2. PubMed ID: 12774726
[No Abstract] [Full Text] [Related]
28. Genetic engineering. New european release rules ratified.
Aldhous P
Nature; 1990 Mar; 344(6265):371. PubMed ID: 2320103
[No Abstract] [Full Text] [Related]
29. Genetic engineering. New law needs changes made.
Dickman S
Nature; 1990 Jan; 343(6256):298. PubMed ID: 2300178
[No Abstract] [Full Text] [Related]
30. Swiss biotech. Government shoots down GM plant trials.
Weiss G
Science; 2001 Dec; 294(5549):2067-9. PubMed ID: 11739923
[No Abstract] [Full Text] [Related]
31. Attack of the anti-cloners: what the government should do.
Caplan A
Free Inq; 2002-2003 Winter; 23(1):30-1. PubMed ID: 16208833
[No Abstract] [Full Text] [Related]
32. Recognizing the need for uniform international regulation of developing biotechnology: a focus on genetic experimentation.
Hanna P
Loyola Los Angel Int Comp Law J; 2002 Jan; 24(1):87-111. PubMed ID: 12769111
[No Abstract] [Full Text] [Related]
33. New technology ethic.
Macer D
Taiwan Yi Xue Ren Wen Xue Kan; 2001 Oct; 2(1-2):41-7. PubMed ID: 15011655
[No Abstract] [Full Text] [Related]
34. US court case to define EST patentability.
Lawrence S
Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
[No Abstract] [Full Text] [Related]
35. Legal rights and genetic engineering.
Stoianoff N
Australas Biotechnol; 1993; 3(5):288-9. PubMed ID: 7764293
[No Abstract] [Full Text] [Related]
36. Toward regulating genetic engineering.
Wilson L
Brethr Life Thought; 1986; 31(4):241-8. PubMed ID: 16715559
[No Abstract] [Full Text] [Related]
37. The logical next step? An international perspective on the issues of human cloning and genetic technology.
Corsover JT
ILSA J Int Law; 1998; 4(2):697-758. PubMed ID: 14626268
[No Abstract] [Full Text] [Related]
38. Protection of health research participants in the United States: a review of two cases.
Douglass A; Crampton P
N Z Bioeth J; 2004 Jun; 5(2):6-12. PubMed ID: 15597497
[TBL] [Abstract][Full Text] [Related]
39. Patenting pluripotence: the next battle for stem cell intellectual property.
Vrtovec KT; Scott CT
Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
[TBL] [Abstract][Full Text] [Related]
40. Russia readies its first gene law.
Allakhverdov A
Science; 1995 Jun; 268(5217):1558. PubMed ID: 7777849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
